文献速递临床试验与 GCP

静脉输注利多卡因对微创食管切除术患者术后肺部并发症的影响:双中心、双盲、随机对照试验研究方案

Effect of intravenous lidocaine infusion on postoperative pulmonary complications in patients undergoing minimally invasive esophagectomy: a study protocol of double-center, double-blind, randomized controlled trial.
PubMed 文献 · Trials · 2025-11-11

本研究为双中心、随机、双盲、安慰剂对照优效性试验,计划纳入770例微创食管切除术患者,按1:1随机分为利多卡因组和安慰剂组,主要结局为术后7天内术后肺部并发症(PPCs)发生率,旨在检验术中静脉输注利多卡因可降低PPCs发生的假设。

要点

  • 拟纳入770例微创食管切除术患者,1:1随机分为利多卡因组与安慰剂组。
  • 主要结局为术后7天内术后肺部并发症(PPCs)发生率。
  • 次要结局包括呼吸道感染、呼吸衰竭、气胸、肺不张、胸腔积液等。

核心结论

  • 本研究旨在检验术中静脉输注利多卡因可降低微创食管切除术患者术后肺部并发症发生率的假设。

研究设计与样本

  • 双中心、随机、双盲、安慰剂对照优效性试验,计划纳入770例参与者,按1:1随机分为利多卡因组和安慰剂组。
  • 原文写明为双中心设计,但方法部分同时表述为来自三个中心的770例参与者,原文此处表述存在矛盾。

主要发现

  • 主要结局为术后7天内术后肺部并发症(PPCs)发生率。
  • 次要结局包括呼吸道感染、呼吸衰竭、气胸、肺不张、胸腔积液、支气管痉挛、吸入性肺炎、吻合口瘘、术后24和48小时静息及咳嗽时中重度疼痛、额外补救镇痛药使用。

局限性

  • 静脉利多卡因输注仅持续至患者转出麻醉后监护室,病房内延长输注的获益将不会被研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Esophageal cancer is the eighth most prevalent malignant tumor in the world and has the sixth highest mortality rate. Postoperative pulmonary complications (PPCs) are one of the most common complications of minimally invasive esophagectomy (MIE). The non-local anesthetic effects of lidocaine have been widely reported, but only a few studies have focused on its effects on lung protection in MIE. This study is designed to test the hypothesis that intraoperative intravenous lidocaine infusion can reduce the incidence of PPCs in patients undergoing MIE. METHODS AND ANALYSIS: In this double-center, randomized, double-blind, placebo-controlled superiority trial, 770 participants from three centers will be randomly assigned to two groups, namely the lidocaine group and the placebo group in a 1:1 ratio. The primary outcome is the incidence of PPCs within 7 days following surgery. The secondary outcomes include the incidence of (1) respiratory infection; (2) respiratory failure; (3) pneumothorax; (4) atelectasis; (5) pleural effusion; (6) bronchospasm; (7) aspiration pneumonitis; (8) anastomotic fistula; (9) moderate to severe pain within 24 and 48 h at rest and when coughing; (10) additional rescue analgesics use. DISCUSSION: This study aims to address a significant gap in the prevention of PPCs in patients undergoing MIE for esophageal cancer. PPCs are common and can negatively impact recovery and survival outcomes, making effective prevention strategies crucial. While lidocaine's non-local anesthetic properties, including anti-inflammatory and analgesic effects, have been well-documented, few studies have focused on its role in lung protection during MIE. By assessing the incidence of PPCs and other secondary outcomes, this trial seeks to determine whether intraoperative lidocaine infusion can offer a novel, non-invasive approach to reducing PPC risk and improving overall postoperative recovery. If lidocaine proves effective, this study will provide a new way to improve patient outcomes, particularly for those with high PPCs risk. Furthermore, the results could expand the scope of lidocaine use in surgical settings, suggesting a potentially low-cost and accessible intervention for broader perioperative lung protection. TRIAL REGISTRATION NUMBERS: NCT06138041 (ClinicalTrials.gov, registration date: 2024-10-22). STRENGTHS AND LIMITATIONS OF THE STUDY: This study will provide a reliable conclusion investigating the effect of intraoperative intravenous lidocaine infusion on postoperative pulmonary complications in patients undergoing minimally invasive esophagectomy. The study includes an appropriate sample size and a double-center, randomized, and double-blind placebo-controlled design, which reduces potential bias. The full analysis set consists of all participants according to the intention-to-treat principle and the per-protocol set will be both performed. Per-protocol analysis will be used for sensitivity analyses. Intravenous lidocaine infusion is only continued until patients are transferred out of the post-anesthesia care unit, while the benefit of prolonged infusion in the ward will not be investigated.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Wang F, Zhang H, Peng X, et al. Effect of intravenous lidocaine infusion on postoperative pulmonary complications in patients undergoing minimally invasive esophagectomy: a study protocol of double-center, double-blind, randomized controlled trial. Trials. 2025. PMID: 41219803. doi:10.1186/s13063-025-09213-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。